TRIMM special seminar by Prof Riitta Lahesmaa

December 3, 2026

Date
03.12.2026
Time
14:00 - 15:00
Location
Biomedicum Helsinki 1, lecture hall 1
Organisation
TRIMM
Contact person
francesca.delorenzo@helsinki.fi

TRIMM special seminar by Prof Riitta Lahesmaa

Novel orchestrators of human regulatory T cells

Speaker: Prof. Riitta Lahesmaa, Professor of Systems Immunology, Director of Turku Bioscience Centre, University of Turku and Åbo Akademi University.

When: Thu 03.12. at 14:00-15:00. Coffee and pulla will be served outside of the hall starting 13.30.

Host: Prof. Satu Mustjoki 

Small bio: Riitta Lahesmaa, M.D., Ph.D. is Professor of Systems immunology and the Director of Turku Bioscience Centre, Turku, Finland (https://bioscience.fi/). Her research group belongs to Research Council of Finland InFLAMES flagship programme. She directs Research Council of Finland IMMUNOCAPS project, that profiles research at the University of Turku.

Dr. Lahesmaa received her M.D. and Ph.D. in immunology from the University of Turku. She was a postdoctoral fellow at Stanford University Medical Center and a Principal Scientist at Roche Bioscience in Palo Alto, California. She has been academy professor and vice-director of the Centre of Excellence in Systems Immunology and Physiology of Research Council of Finland. She has also been a visiting professor in Harvard Medical School, Stanford Medical School and UCSF.

Dr. Lahesmaa’s research group aims at understanding regulation of immune response and molecular mechanisms of type 1 diabetes (T1D)  and other human immune mediated and inflammatory diseases. The studies have resulted in the identification of novel molecular mechanisms and new regulators of T cell functions and very early changes in immune response associated with development of T1D. She has participated to a number of EU-funded consortia and projects. She has published > 250 original papers and reviews and has several issued patents and patent applications. She is an elected member of the Finnish Academy of Science and Letters and EMBO.